Jan 23 (Reuters) - Novo Nordisk A/S NOVOb.CO :
* XULTOPHY® NOW AVAILABLE IN CANADA TO SUPPORT IMPROVED GLYCEMIC CONTROL, AN ISSUE FACING 50 PER CENT OF CANADIANS WITH TYPE 2 DIABETES
Jan 23 (Reuters) - Novo Nordisk A/S NOVOb.CO :
* XULTOPHY® NOW AVAILABLE IN CANADA TO SUPPORT IMPROVED GLYCEMIC CONTROL, AN ISSUE FACING 50 PER CENT OF CANADIANS WITH TYPE 2 DIABETES